DNA Sequencing Market to Witness a Healthy CAGR of 20.5% with USD 70.74 Billion by 2032

According to the latest market research the "DNA Sequencing Market by Product and Services (Instruments, Consumables, Services), by Technology, by Application, by End Use, by Region - Global Forecast to 2032", is anticipated to grow from USD 13.23 billion in 2023 to USD 70.74 billion by 2032, exhibiting a CAGR of 20.5% during the forecast period, 2024-2032.

DNA sequencing refers to the process of determining the order of nucleotides, which are the four building blocks that make up the DNA molecule. Sequencing all of an organism's DNA, which involves breaking the DNA into several smaller pieces, remains a sophisticated task.

However, the advent of new technologies over the past two decades has reduced the cost and accelerated the speed of DNA sequencing. The process of sequencing genomes now finds applications in clinical investigation, oncology, consumer genomics, forensics, and metagenomics, amongst others.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/dna-sequencing-market/request-for-sample

Sanger sequencing, next-generation sequencing, and third-generation sequencing are the common methods used to perform DNA sequencing. Sanger sequencing involves copying the DNA multiple times and fragmenting it into different lengths, whereas next-gen sequencing methods are meant to improve the speed and reduce the cost of DNA sequencing. The aging population, advances in technology and lifestyle changes are the primary factors driving the DNA sequencing market demand.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

• DNA Sequencing Market Share Analysis (2023)
• Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Leading Players Featured in the Report Industry participants are focusing on the introduction of new products to expand their reach and bolster their market presence.

𝐒𝐨𝐦𝐞 𝐎𝐟 𝐓𝐡𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐈𝐧 𝐓𝐡𝐞 𝐃𝐍𝐀 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐫𝐞:

• Abcam plc
• Agilent Technologies, Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Biolabs, Inc.
• Cell Signaling Technology, Inc.
• Danaher Corporation
• GenScript Biotech Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Promega Corporation
• Qiagen N.V.
• SignalChem Pharmaceuticals Inc.
• Thermo Fisher Scientific Inc.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3653/2

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

• The market segmentation is primarily based on product types and services, technology, application, end-use, and region.

• By application analysis, the oncology segment accounted for a significant revenue share owing to its role in precision medicine and early cancer detection.

• By end-use analysis, the academic research segment held a major revenue share as substantial funding allows them to invest in sequencing techniques and consumables.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/dna-sequencing-market

𝐃𝐍𝐀 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:

• In 2023, the consumables segment held significant revenue share owing to high utilization rate, frequent repurchase, and diverse applications.

• In 2023, the next-generation sequencing segment held significant revenue share owing to enhanced throughput, cost-effectiveness, and growing applications in clinical diagnostics.

• In 2023, the oncology segment held significant revenue share owing to focus on precision medicine, early detection and diagnosis, and monitoring treatment response.

• In 2023, the academic research segment held significant revenue share owing to funding allocation, research intensity, and grant requirements.

• In 2023, North America region dominated the global market due to robust healthcare infrastructure, government funding, and high prevalence of genetic disorders.

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

𝐄𝐝𝐠𝐞 𝐀𝐈 𝐇𝐚𝐫𝐝𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/edge-ai-hardware-market-powering-intelligence-forecast-mohit-harne-g8n2f

𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜 𝐃𝐞𝐬𝐢𝐠𝐧 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/electronic-design-automation-market-driving-innovation-8gqkf

𝐈𝐧𝐭𝐫𝐚𝐜𝐫𝐚𝐧𝐢𝐚𝐥 𝐒𝐭𝐞𝐧𝐨𝐬𝐢𝐬 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/intracranial-stenosis-stents-market-advancements-neurovascular-dzyuf

𝐌𝐞𝐭𝐚𝐥𝐥𝐢𝐜 𝐒𝐭𝐞𝐚𝐫𝐚𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/metallic-stearates-market-enhancing-performance-9shkf

𝐍𝐚𝐧𝐨𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/nanomedicine-market-transforming-healthcare-molecular-bkkef

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.